Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Xiaoying Granules
- Development stage
- Unknown
- Lead developer
- Tianjiang Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Compound Xiaoying Granules (复方消瘿颗粒) is a Traditional Chinese Medicine (TCM) formulation developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is primarily indicated for the treatment of Graves' disease, particularly in patients presenting with the TCM syndrome of yin deficiency and phlegm-heat. The granules are often used as an adjunctive therapy alongside standard antithyroid drugs like methimazole to improve clinical symptoms, reduce thyroid volume, and modulate thyroid hormone levels. The formula typically contains botanical extracts aimed at clearing heat, resolving phlegm, and softening hard masses (goiter). Clinical studies have focused on its ability to regulate thyroid hormones (T3, T4, TSH) and reduce thyroid-stimulating immunoglobulin (TSI) levels.
- Other names
- Fufang Xiaoying GranulesXiaoying Granules
02
Targets
TSHR (Thyroid-stimulating hormone receptor)
Beyond the preview
Go deeper on Compound Xiaoying Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Compound Xiaoying Granules.